House Committees Demand F.D.A. Records on Alzheimer’s Drug Approval
The agency approved Biogen’s Aduhelm “despite concerns raised by experts,” [...]
F.D.A. Seeks Investigation of Its Own Alzheimer’s Drug Approval
The agency’s acting head said a review should look into [...]